sciensano.be
Publié sur sciensano.be (https://www.sciensano.be)

Accueil > Biblio > Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

Surveillance de la santé et des maladies  

Peer reviewed scientific article

Anglais

SCIENSANO

Auteurs

Ariën, Kevin K [1]

Mots-clés

    Résumé:

    We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.
    Lire la suite

    Résumé

    We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.

    Associated health topics:

    Surveillance de la santé et des maladies [2]

    Source URL:https://www.sciensano.be/fr/biblio/three-doses-bnt162b2-vaccine-confer-neutralising-antibody-capacity-against-sars-cov-2-omicron

    Liens
    [1] https://www.sciensano.be/fr/biblio?f%5Bauthor%5D=68628&f%5Bsearch%5D=Ari%C3%ABn%2C%20Kevin%20K [2] https://www.sciensano.be/fr/sujets-sante/surveillance-de-la-sante-et-des-maladies